Skip to main content
Tammy Wichman, MD, Pulmonology, Omaha, NE

TammyJWichmanMD

Pulmonology Omaha, NE

Critical Care Medicine, Pleural Disease

Associate Professor of Medicine University of Nebraska School of Medicine

Dr. Wichman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wichman's full profile

Already have an account?

  • Office

    Emile 42nd St
    Omaha, NE 68198
    Phone+1 402-559-4015
    Fax+1 402-559-8715

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2003
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine/Pediatrics, 1996 - 2000
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1996

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2003 - 2026
  • VA State Medical License
    VA State Medical License 1998 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ Signatures
    ‘Health Care Works Are Exhausted,’ UNMC Letter Receives 2k+ SignaturesNovember 18th, 2020
  • Targeted Therapy with Phosphodiesterase 5 Inhibitors in Patients with Pulmonary Hypertension Due to Heart Failure and Elevated Pulmonary Vascular Resistance: A Systematic Review
    Targeted Therapy with Phosphodiesterase 5 Inhibitors in Patients with Pulmonary Hypertension Due to Heart Failure and Elevated Pulmonary Vascular Resistance: A Systematic ReviewOctober 7th, 2020